ENERGI-F703 matched vehicle

DRUG2 trials

Sponsors

Energenesis Biomedical Co., Ltd.

Conditions

Diabetes MellitusDiabetic FootDiabetic Foot UlcerFoot UlcerWoundWounds

Phase 2

ENERGI-F703 for Diabetic Foot Ulcers Phase II Study

CompletedNCT02672436

Energenesis Biomedical Co., Ltd.Diabetes Mellitus, Diabetic Foot, Foot Ulcer +1

Start: 2017-03-15End: 2019-12-26Updated: 2020-11-24

Phase 3

A Study to Evaluate ENERGI-F703 GEL in Diabetic Foot Ulcer

RecruitingNCT05930210

Energenesis Biomedical Co., Ltd.Diabetes Mellitus, Diabetic Foot Ulcer, Foot Ulcer +1

Start: 2023-05-30End: 2026-03-31Target: 230Updated: 2025-10-02

Related Papers

ENERGI-F703 gel, as a new topical treatment for diabetic foot and leg ulcers: A multicenter, randomized, double-blind, phase II trial.

2022-07-104 citations